risk-management

To manage AI risks under Article 9 of the EU AI Act, you need an end-to-end system that facilitates compliance assessment, implements risk controls, and establishes continuous monitoring for health and safety adherence.

An Article 9 compliance assessment involves evaluating your AI systems against EU AI Act requirements to identify health and safety risks and deploy appropriate regulatory controls and measures for adherence.

Implementing safety controls for AI systems involves deploying appropriate measures identified during risk assessment to mitigate health and safety risks and ensure regulatory adherence under Article 9.

Yes, managing AI risks per Article 9 includes establishing ongoing continuous monitoring and review processes to ensure AI systems remain compliant with health and safety regulatory standards over time.

Yes, risk management for Article 9 applies to AI medical diagnostic tools by assessing potential health risks, implementing necessary safety controls, and documenting compliance with regulatory standards.

Generic risk management may lack the specific mechanisms needed for EU AI Act compliance, such as continuous monitoring processes and targeted health and safety controls required explicitly by Article 9.